Abilify, Nexium, Humira lead list of best-selling drugs in U.S.

05/14/2014 | Medscape (free registration)

A new report from IMS Health showed that Otsuka Pharmaceutical's antipsychotic drug Abilify, or aripiprazole, continues to be the best-selling drug in the U.S., with almost $6.9 billion in sales from April 2013 to March 2014. AstraZeneca's proton pump inhibitor Nexium, or esomeprazole, ranked second, with almost $6.3 billion in sales, followed by AbbVie's arthritis drug Humira, or adalimumab, with sales of $5.9 billion. The two most-prescribed drugs during the period were AbbVie's hypothyroid drug Synthroid and AstraZeneca's cholesterol-lowering drug Crestor.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory FDA
Cardinal Health
Columbus, OH
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA